Janel Corp (JANL)
35.45
0.00 (0.00%)
USD |
OTCM |
Apr 24, 16:00
Price Chart
Key Stats
| Price and Performance | |
|---|---|
| Market Cap | 42.06M |
| 52 Week High (Daily) | Upgrade |
| 52 Week Low (Daily) | Upgrade |
| All-Time High (Daily) | Upgrade |
| Year to Date Total Returns (Daily) | Upgrade |
| 1 Month Total Returns (Daily) | Upgrade |
| 1 Year Total Returns (Daily) | 31.30% |
| Valuation | |
| PE Ratio | 126.61 |
| PE Ratio (Forward) | Upgrade |
| PS Ratio | 0.2527 |
| Price to Book Value | 2.185 |
| EV to EBITDA | Upgrade |
| Dividend | |
|---|---|
| Dividend | -- |
| Dividend Yield (Forward) | Upgrade |
| Financials | |
| Revenue (5 Year Growth) | Upgrade |
| Revenue (Quarterly YoY Growth) | Upgrade |
| EPS Diluted (5 Year Growth) | Upgrade |
| EPS Diluted (Quarterly YoY Growth) | Upgrade |
| Debt to Equity Ratio | 1.444 |
| Return on Equity | Upgrade |
| Return on Assets | Upgrade |
| Risk | |
| Beta (5Y) | Upgrade |
| Max Drawdown (5Y) | 69.15% |
Profile
| Janel Corp is a holding company. The company's operating segments include Logistics Services, Manufacturing, and Life Sciences. The logistics Services segment is a full-service provider of cargo transportation logistics management services, including freight forwarding via air, ocean, and land-based carriers, customs brokerage services, warehousing, and distribution services. The Manufacturing segment is engaged in manufacturing and distributing industrial mixing equipment and apparatus for specific applications within various industries. The Life Sciences segment manufactures and distributes monoclonal and polyclonal antibodies, diagnostic reagents, and other immunoreagents for biomedical research. It generates maximum revenue from the Logistics Services segment. |
| URL | https://www.janelcorp.com |
| Investor Relations URL | N/A |
| HQ State/Province | New York |
| Sector | Industrials |
| Industry | Air Freight & Logistics |
| Equity Style | Small Cap/Value |
| Next Earnings Release | May. 03, 2024 (est.) |
| Last Earnings Release | Feb. 02, 2024 |
| Next Ex-Dividend Date | N/A |
| Last Ex-Dividend Date | N/A |
Ratings
Profile
| Janel Corp is a holding company. The company's operating segments include Logistics Services, Manufacturing, and Life Sciences. The logistics Services segment is a full-service provider of cargo transportation logistics management services, including freight forwarding via air, ocean, and land-based carriers, customs brokerage services, warehousing, and distribution services. The Manufacturing segment is engaged in manufacturing and distributing industrial mixing equipment and apparatus for specific applications within various industries. The Life Sciences segment manufactures and distributes monoclonal and polyclonal antibodies, diagnostic reagents, and other immunoreagents for biomedical research. It generates maximum revenue from the Logistics Services segment. |
| URL | https://www.janelcorp.com |
| Investor Relations URL | N/A |
| HQ State/Province | New York |
| Sector | Industrials |
| Industry | Air Freight & Logistics |
| Equity Style | Small Cap/Value |
| Next Earnings Release | May. 03, 2024 (est.) |
| Last Earnings Release | Feb. 02, 2024 |
| Next Ex-Dividend Date | N/A |
| Last Ex-Dividend Date | N/A |